Adenosine monophosphate-activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ischemia-reperfusion injury in the rat

Hepatology

Volumn 34, Issue 6, 2001, Pages 1164-1173

  Peralta, Carmen ^a   Bartrons, Ramón ^b   Serafin, Anna ^a   Blázquez, Cristina ^c   Guzmán, Manuel ^c   Prats, Neus ^d   Xaus, Carme ^a   Cutillas, Blanca ^b   Gelpí, Emilio ^a   Roselló Catafau, Joan ^a  

^a INST D INVESTIGACIONS B   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LACTIC ACID; NITRIC OXIDE; PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME ACTIVATION; LIVER CELL; LIVER INJURY; LIVER ISCHEMIA; LIVER PROTECTION; LIVER RESECTION; LIVER SURGERY; LIVER TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 0035189594     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.29197     Document Type: Article

References (45)

1. Vascular occlusions for liver resections. Operative management and tolerance to hepatic ischemia; 142 cases
2. Homotransplantation of the liver
3. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies
4. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium
5. + channels in cerebral ischemic preconditioning
6. Intestinal preconditioning is mediated by a transient increase in nitric oxide
7. Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: Role of nitric oxide and adenosine
8. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans
9. Hepatic preconditioning preserves energy metabolism during sustained ischemia
10. Hepatic preconditioning in rats is defined by a balance of adenosine and xanthine
11. The AMP-activated/SNF1 protein kinase subfamily: Metabolic sensors of the eukaryotic cell?
12. The regulation of AMP-activated protein kinase by phosphorylation
13. Dealing with energy demand: The AMP-activated protein kinase
14. 5-Aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?
15. Inhibition of glycolysis by 5-amino-4-imidazolecarboxamide riboside in isolated rat hepatocytes
16. Cell-type specificity of inhibition of glycolysis by 5-amino-4-imidazolecarboxamide riboside. Lack of effect in rabbit cardiomyocytes and human erythrocytes, and inhibition in FTO-2B rat hepatoma cells
17. The 5′-AMP-activated protein kinase inhibits the transcriptional stimulation by glucose in liver cells, acting through the glucose response complex
18. Control of hepatic fatty acid oxidation by 5′-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism
19. Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase
20. The protective role of adenosine in inducing nitric oxide synthesis in rat liver ischemic preconditioning is mediated by activation of adenosine A2 receptors
21. AMP-activated protein kinase phosphorylation of endothelial NO synthase
22. Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism
23. Modification of glyceraldehyde-3-phosphate dehydrogenase in response to nitric oxide in intestinal preconditioning
24. Acadesine and myocardial protection. Studies of time of administration and dose-response relations in the rat
25. Sustained protection by acadesine against ischemia- and reperfusion-induced injury. Studies in the transplanted rat heart
26. Effects of adenine nucleotide analogues on myocardial dysfunction during reperfusion after ischemia in dogs
27. Insulin activation of acetyl-CoA carboxylase accompanied by inhibition of the 5′-AMP-activated protein kinase
28. Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR
29. Effects of adenosine and its derivatives on the canine intestinal vasculature
30. Activation of caspase 3 (CPP32)-like proteases is essential for TNF-alpha-induced hepatic parenchymal cell apoptosis and neutrophil-mediated necrosis in a murine endotoxine schock model
31. ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF-alpha
32. Liver AMP-activated protein kinase and acetyl-CoA carboxylase during and after exercise
33. Tissue distribution of the AMP-activated protein kinase, and lack of activation by cyclic-AMP- dependent protein kinase, studied using a specific and sensitive peptide assay
34. Reduction of ischemia-reperfusion injury of the liver in vivo adenovirus-mediated gene transfer of the antiapoptotic Bcl-2 gene
35. The portosystemic shunt protects liver against ischemic reperfusion injury
36. Hepatocellular degeneration and death
37. Amelioration of lactic acid with dichloroacetate during liver transplantation in humans
38. Phosphoenolpyruvate prevents the decline in hepatic ATP and energy charge after ischemia and reperfusion injury in rats
39. The AMPK-activated protein kinase. Fuel gauge of the mammalian cell?
40. Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia
41. Metabolic control: A new solution to an old problem
42. Failure of AICA riboside to limit infarct size during acute myocardial infarction in rabbits
43. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction
44. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle
45. Effects of denosine and acadesine on interstitial nucleosides and myocardial stunning in the pig